Project Grant P30GM154632

Award Date 7/15/24
Completion Date 5/31/29
Dollars Obligated $1.1M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
South Carolina, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $2,199,676 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of South Carolina (USC) to establish the Center for Clinical and Translational Research at USC (CLINTRUSC). The overarching goal of this 5-year award is to build sustainable clinical and translational research capacity at USC, which is strategically located in the Midlands region of South Carolina, an area facing...
This $361,107 Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), will support two key research focus areas at Clemson University: Developing new synthetic methodology to access rare, medicinally-relevant nitrogen-rich heterocyclic compounds, with the goal of expanding the availability of these densely functionalized molecules for biological evaluation and application. This work...
The National Institute of General Medical Sciences (NIGMS) awarded a $138,334 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Southern California (USC) to develop a scalable computational platform for ligand discovery. The goal is to synergistically combine structure-based and data-driven approaches to accelerate the discovery of selective and potent ligands for novel therapeutic targets. The research will focus on three key directions: 1) Improving...
The National Institute of General Medical Sciences (NIGMS) awarded a $2,179,141 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Montana to establish the Montana Clinical and Translational Research Center (Montana CTRC). The primary objectives of this 5-year grant, effective September 1, 2024, are to: 1) Provide mentorship and workforce development to enhance capacity for clinical and translational research in Montana's rural and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA Program 93.859 - Biomedical Research and Research Training will provide $1,116,183 from July 15, 2024 to May 31, 2029 to establish the Center for Dietary Supplements and Inflammation (CDSI) at the University of South Carolina School of Medicine. The CDSI will investigate how botanical and natural product compounds can attenuate inflammation and understand the mechanisms that trigger chronic...
This $334,233 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program aims to conduct innovative research on cancer health disparities in South Carolina. The key products and services to be delivered include: Examining patterns of novel targeted cancer therapies and their impact on survival disparities by race, socioeconomic status, and urban/rural location. Describing the individual and joint effects of cancer treatment...
The National Institute of General Medical Sciences (NIGMS) awarded a $415,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Southern California (USC) to establish a high-throughput, quantitative structural cell biology platform to identify cellular mechanisms that enhance secretory efficiency. The project aims to leverage soft X-ray tomography and fluorescence lifetime imaging microscopy to map cell organization, quantify molecular packing of...
The Medical University of South Carolina (MUSC) was awarded a $792,245 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LEVERAGING LINEAGE ADDICTION: NUCLEAR DELIVERY OF THERAPEUTIC TRANSGENES RESPONSIVE TO ONCOGENIC TRANSCRIPTION FACTOR OVEREXPRESSION," will fund research focused on developing innovative gene therapy approaches to treat various medical conditions. The award has a performance...
The National Institute of General Medical Sciences (NIGMS) awarded a $2,512,190 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Sanford Research, a non-profit biomedical research organization located in Sioux Falls, South Dakota. The grant, spanning July 2024 to June 2029, supports the Center for Pediatric Research in advancing basic and translational scientific investigations into the developmental origins of pediatric diseases and disorders. Key...
This federal Project Grant award of $335,578 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is aimed at developing chemical and biological tools to study five-carbon (C5) metabolism and its role in cellular physiology and disease. The key products and services to be provided under this grant include: Creating next-generation cell-permeable C5 analogs and inhibitors targeting the enzyme isopentenyl pyrophosphate...

The National Institute of General Medical Sciences (NIGMS) awarded a $1,117,500 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of South Carolina (USC) to establish the Center for Targeted Therapeutics (CTT). The CTT supports high-impact research projects in targeted therapeutics, maintains core research infrastructure, and promotes collaborative networking to advance the field of translational biomedical research.

Key activities include:

  1. Funding pilot research projects, with a focus on engaging junior faculty, collaborative studies, and underserved investigators.
  2. Sustaining three strategic research core facilities in functional genomics, drug discovery synthesis, and microscopy/flow cytometry.
  3. Organizing center meetings, seminars, and training to develop multi-investigator and SBIR/STTR grant applications.

The award, effective July 15, 2024, supports the CTT's transition to self-sufficiency and sustainability after its initial establishment in 2014. The program aims to continue developing USC's capabilities and critical mass in targeted therapeutics research, ultimately enhancing the state's biomedical research profile and benefiting public health.

Generated 4/29/25, 3:24 AM